1. Home
  2. CDW vs BNTX Comparison

CDW vs BNTX Comparison

Compare CDW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDW
  • BNTX
  • Stock Information
  • Founded
  • CDW 1984
  • BNTX 2008
  • Country
  • CDW United States
  • BNTX Germany
  • Employees
  • CDW N/A
  • BNTX N/A
  • Industry
  • CDW Catalog/Specialty Distribution
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CDW Consumer Discretionary
  • BNTX Health Care
  • Exchange
  • CDW Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • CDW 23.7B
  • BNTX 23.9B
  • IPO Year
  • CDW 1993
  • BNTX 2019
  • Fundamental
  • Price
  • CDW $180.62
  • BNTX $117.20
  • Analyst Decision
  • CDW Buy
  • BNTX Strong Buy
  • Analyst Count
  • CDW 8
  • BNTX 14
  • Target Price
  • CDW $244.63
  • BNTX $141.60
  • AVG Volume (30 Days)
  • CDW 1.6M
  • BNTX 1.1M
  • Earning Date
  • CDW 10-30-2024
  • BNTX 11-04-2024
  • Dividend Yield
  • CDW 1.38%
  • BNTX N/A
  • EPS Growth
  • CDW 2.13
  • BNTX N/A
  • EPS
  • CDW 8.18
  • BNTX N/A
  • Revenue
  • CDW $20,831,200,000.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • CDW N/A
  • BNTX N/A
  • Revenue Next Year
  • CDW $3.08
  • BNTX N/A
  • P/E Ratio
  • CDW $22.08
  • BNTX N/A
  • Revenue Growth
  • CDW N/A
  • BNTX N/A
  • 52 Week Low
  • CDW $172.95
  • BNTX $76.53
  • 52 Week High
  • CDW $263.37
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • CDW 38.73
  • BNTX 56.37
  • Support Level
  • CDW $175.76
  • BNTX $101.02
  • Resistance Level
  • CDW $183.00
  • BNTX $121.80
  • Average True Range (ATR)
  • CDW 4.23
  • BNTX 5.84
  • MACD
  • CDW 0.71
  • BNTX 1.58
  • Stochastic Oscillator
  • CDW 32.21
  • BNTX 83.27

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has three operating segments namely, Corporate, Small Business, and Public. The Corporate segment generates the majority of its revenue and primarily serves US private sector business customers with more than 250 employees.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: